SBIR/STTR Research Award
Expanding the Redox Biology Toolbox
Award amount
$150,000Program and phase
SBIR · Phase IAward year
2020Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- Chemical Biology Probes LLC
- Proposal award date
- 2020-07-01
- Contract end date
- 2021-06-30
- UEI
- CNZVA1958JZ1
- Solicitation number
- PA19-272
- Topic code
- 300
Research abstract
AbstractGlutathione (GSH) is the most abundant non-protein thiol in eukaryotic cells. GSH maintains cellular redox
homeostasis and is involved in numerous biological processes. These important functions are dynamically
regulated by the intracellular concentration and distribution of GSH. Currently, the concentration of intracellular
GSH is derived from either cell lysates or GSH-S-transferase (GST) dependent probes. These approaches,
however, cannot provide information about the real-time dynamics of GSH concentration changes. We reported
the first reversible reaction-based GSH probe (ThiolQuant Green) that can perform single-point quantification of
GSH levels in living cells and developed the 2nd generation GSH probe—RealThiol (RT)—that allows real-time
monitoring of GSH dynamics in living cells. We filed a patent on these GSH probes (WO2016025382) and have
shared the RealThiol probe with andgt;70 redox biology labs around the world. Additionally, the Division of Cancer
Treatment andamp; Diagnosis Laboratory Support at National Cancer Institute (NCI) is interested in applying our GSH
probes in their drug screening assays and requested gram quantity of RT probes. The overarching goal for this
Phase I project is to develop probes that can monitor the dynamics of the concentration change of GSH in real-
time with subcellular specificity and to provide a complete toolset to study GSH-related redox biology. For Phase
II commercialization, we will focus on both basic and clinical research. We will develop assay kits for GSH-related
biology, such as ferroptosis. We will also apply our GSH probes in clinical samples to help identify patients with
drug/radiation-resistant tumors.Project Narrative
The overarching goals of this project are to develop a complete toolset for GSH quantification in cells and cellular
organelles. The accessibility of reliable tools will enable tremendous opportunity for new basic and translational
redox biology studies.
Technology keywords
Not reported
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- A platform for T-cell receptor mimic antibody generation modeled using pHLA-A*11:01 KRAS G12D
- Combinatorial pipeline for discovery of anti-GPCR Nanobodies
- Development of a GBP-based glycosylation analysis system
- Extended-release injectable gel for multi-day treatment of postoperative pain
- eMOA: A Multi-Omic Service for Mechanism of Action Determination in Drug Screening